At a glance
21% of SCHD’s and VYM’s holdings overlap by weight, with 80 securities in common out of 99 and 604. SCHD is an ordinary open-end ETF and VYM a share class of Vanguard High Dividend Yield Index Fund, which also sells mutual fund shares. VYM costs less: 0.04% a year against 0.06% for SCHD, or $40 against $60 on every $100,000. SCHD has $112.34B in assets and VYM $99.19B (all share classes); over the past 12 months SCHD paid out 2.95% of its price and VYM 2.25%, both quarterly. Over the past year SCHD returned +38.9% and VYM +19.1% with distributions reinvested; over five years, +10.5% and +11.8% a year. In the 2022 bear market SCHD fell 16.8% at its worst and VYM 15.9%; SCHD was back at its earlier high 15 months after the low, VYM 2 months.
Key differences
| SCHD | VYM | |
|---|---|---|
| Fund | Schwab US Dividend Equity ETF | Vanguard High Dividend Yield Index ETF |
| Issuer | Schwab | Vanguard |
| Structure | Open-end ETF | ETF share class |
| Type | Dividend | High dividend |
| Launched | Oct 20, 2011 | Nov 10, 2006 |
| Expense ratio | 0.06% | 0.04% |
| Cost a year on $100,000 | $60 | $40 |
| Net assets | $112.34B | $99.19B * |
| Holdings | 99 | 604 |
| Ten largest positions | 41.7% | 26.1% |
| Yield (12 months) | 2.95% | 2.25% |
| Pays | quarterly | quarterly |
| Portfolio turnover | 30% a year | 11% a year |
| Price data from | Oct 20, 2011 | Jun 2, 2020 |
Holdings and overlap
Overlap adds up, for every security both funds own, the smaller of its two weights: 100% would mean identical portfolios.
Largest holdings
| Holding | SCHD | VYM |
|---|---|---|
| Broadcom Inc | — | 7.35% |
| Merck & Co Inc | 4.76% | 1.31% |
| Amgen Inc | 4.70% | 0.78% |
| Abbott Laboratories | 4.68% | 0.74% |
| Coca-Cola Co | 4.16% | 1.38% |
| Chevron Corp | 4.01% | 1.48% |
| Verizon Communications Inc | 3.96% | 0.80% |
| ConocoPhillips | 3.93% | 0.60% |
| Home Depot Inc | 3.87% | 1.34% |
| Procter & Gamble Co | 3.82% | 1.37% |
| JPMorgan Chase & Co | — | 3.82% |
| UnitedHealth Group Inc | 3.82% | 1.52% |
The biggest differences in weight: Broadcom Inc (0.0% in SCHD, 7.4% in VYM); Abbott Laboratories (4.7% in SCHD, 0.7% in VYM); Amgen Inc (4.7% in SCHD, 0.8% in VYM).
By sector
| Sector | SCHD | VYM | Difference |
|---|---|---|---|
| Health care | 21.3% | 12.1% | SCHD +9.2 |
| Consumer staples | 17.7% | 7.2% | SCHD +10.5 |
| Financials | 5.2% | 17.4% | VYM +12.2 |
| Technology | 5.6% | 14.5% | VYM +8.9 |
| Energy | 12.7% | 5.4% | SCHD +7.3 |
| Industrials | 9.0% | 9.1% | VYM +0.1 |
| Consumer discretionary | 7.2% | 4.6% | SCHD +2.6 |
| Utilities | 0.0% | 4.2% | VYM +4.2 |
| Communication services | 2.3% | 2.1% | SCHD +0.2 |
| Materials | 0.9% | 1.5% | VYM +0.6 |
Returns
$10,000 put into SCHD on Jun 30, 2020 was worth $25,852 on Oct 30, 2026, and in VYM $24,949 (+16.2% and +15.5% a year). That is as far back as the price data for both goes.
| 1 yr | 3 yr | 5 yr | 10 yr | |
|---|---|---|---|---|
| SCHD price data to Nov 2, 2026 | +38.9% | +19.9% | +10.5% | +13.9% |
| SCHD official prospectus, to Dec 31, 2024 | +11.60% | — | +11.03% | +11.03% |
| VYM price data to Oct 30, 2026 | +19.1% | +21.2% | +11.8% | — |
| VYM official prospectus, to Dec 31, 2025 | +15.43% | — | +12.68% | +11.32% |
Calendar years
| Year | SCHD | VYM | Difference |
|---|---|---|---|
| 2026 | +34.1% * | +16.1% * | SCHD +18.0 |
| 2025 | +4.3% | +15.4% | VYM +11.1 |
| 2024 | +11.6% | +17.6% | VYM +5.9 |
| 2023 | +4.6% | +6.6% | VYM +2.0 |
| 2022 | -3.2% | -0.5% | VYM +2.8 |
| 2021 | +29.9% | +26.2% | SCHD +3.7 |
| 2020 | +15.1% | +1.14% † | |
| 2019 | +27.3% | +24.20% † | |
| 2018 | -5.5% | -5.87% † | |
| 2017 | +20.9% | — |
Downturns and recovery
| SCHD | VYM | |
|---|---|---|
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before it launched | Not in the price data (starts Jun 2, 2020) |
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | −32.8% at the worst; back at its high 5 months after the low | Not in the price data (starts Jun 2, 2020) |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | −16.8% at the worst; back at its high 15 months after the low | −15.9% at the worst; back at its high 2 months after the low |
| Worst fall in the price data | −33.4% (Jan 23, 2020 – Mar 23, 2020) | −15.9% (Apr 20, 2022 – Sep 30, 2022) |
Income
| Year | SCHD | VYM |
|---|---|---|
| 2025 | $384 | $274 |
| 2024 | $389 | $313 |
| 2023 | $351 | $322 |
| 2022 | $317 | $290 |
| 2021 | $351 | $339 |
Costs
VYM charges 0.04% a year and SCHD 0.06%: on $100,000 that is $20 a year less with VYM ($100 on $500,000). The fee comes out of each fund's assets, so it is already in the returns above.
| Cost of $10,000 (SEC example) | 1 yr | 3 yrs | 5 yrs | 10 yrs |
|---|---|---|---|---|
| SCHD | $6 | $19 | $34 | $77 |
| VYM | $4 | $13 | $23 | $51 |